Platelet activation risk index as a prognostic thrombosis indicator.

K E Zlobina, G Th Guria
Author Information
  1. K E Zlobina: National Research Center for Hematology, 125167, Novy Zykovsky pr. 4, Moscow, Russia.
  2. G Th Guria: National Research Center for Hematology, 125167, Novy Zykovsky pr. 4, Moscow, Russia.

Abstract

Platelet activation in blood flow under high, overcritical shear rates is initiated by Von Willebrand factor. Despite the large amount of experimental data that have been obtained, the value of the critical shear rate, above which von Willebrand factor starts to activate platelets, is still controversial. Here, we recommend a theoretical approach to elucidate how the critical blood shear rate is dependent on von Willebrand factor size. We derived a diagram of platelet activation according to the shear rate and von Willebrand factor multimer size. We succeeded in deriving an explicit formula for the dependence of the critical shear rate on von Willebrand factor molecule size. The platelet activation risk index was introduced. This index is dependent on the flow conditions, number of monomers in von Willebrand factor, and platelet sensitivity. Probable medical applications of the platelet activation risk index as a universal prognostic index are discussed.

References

  1. Blood. 1996 Oct 15;88(8):2939-50 [PMID: 8874190]
  2. Thromb J. 2015 Feb 05;13:8 [PMID: 25688179]
  3. Cell Mol Life Sci. 2015 Jan;72(2):307-26 [PMID: 25297919]
  4. Nature. 2001 Oct 4;413(6855):488-94 [PMID: 11586351]
  5. Microcirculation. 2009 Jan;16(1):58-83 [PMID: 19191170]
  6. Nat Commun. 2016 Jan 06;7:10176 [PMID: 26733371]
  7. Proc Natl Acad Sci U S A. 2007 May 8;104(19):7899-903 [PMID: 17470810]
  8. Blood. 2003 Apr 1;101(7):2637-45 [PMID: 12456504]
  9. J Clin Invest. 1998 Jan 15;101(2):479-86 [PMID: 9435321]
  10. Biophys J. 2009 Nov 4;97(9):2567-76 [PMID: 19883600]
  11. Nature. 2010 Aug 19;466(7309):992-5 [PMID: 20725043]
  12. J Clin Invest. 1986 Dec;78(6):1456-61 [PMID: 3491092]
  13. Blood Coagul Fibrinolysis. 2014 Apr;25(3):206-16 [PMID: 24448155]
  14. Thromb Res. 2010 Dec;126(6):543-9 [PMID: 20889192]
  15. PLoS One. 2015 Jul 29;10(7):e0134028 [PMID: 26222505]
  16. Blood. 2006 Sep 15;108(6):1903-10 [PMID: 16772609]
  17. Blood. 1996 Sep 1;88(5):1525-41 [PMID: 8781407]
  18. J Thromb Haemost. 2006 Oct;4(10 ):2103-14 [PMID: 16889557]
  19. Haemophilia. 2008 Nov;14 Suppl 5:11-26 [PMID: 18786007]
  20. Haematologica. 2013 Nov;98(11):1810-8 [PMID: 23753027]
  21. Acta Haematol. 2009;121(2-3):71-84 [PMID: 19506352]
  22. J Phys Chem B. 2014 May 29;118(21):5660-9 [PMID: 24754487]
  23. Nat Med. 2009 Jun;15(6):665-73 [PMID: 19465929]
  24. Annu Rev Med. 2015 ;66:211-25 [PMID: 25587650]
  25. Biophys Chem. 2010 Dec;153(1):1-8 [PMID: 20797815]
  26. Blood Rev. 2015 Nov;29(6):377-86 [PMID: 26005062]
  27. IEEE Trans Biomed Eng. 2015 Jul;62(7):1718-27 [PMID: 25706500]
  28. Blood. 2014 Aug 28;124(9):1412-25 [PMID: 24928861]
  29. PLoS One. 2013;8(3):e59372 [PMID: 23555663]

MeSH Term

Humans
Models, Theoretical
Platelet Activation
Protein Unfolding
Risk Factors
Thrombosis
von Willebrand Factor

Chemicals

von Willebrand Factor

Word Cloud

Created with Highcharts 10.0.0WillebrandfactoractivationshearvonindexrateplateletcriticalsizeriskPlateletbloodflowdependentprognostichighovercriticalratesinitiatedVonDespitelargeamountexperimentaldataobtainedvaluestartsactivateplateletsstillcontroversialrecommendtheoreticalapproachelucidatederiveddiagramaccordingmultimersucceededderivingexplicitformuladependencemoleculeintroducedconditionsnumbermonomerssensitivityProbablemedicalapplicationsuniversaldiscussedthrombosisindicator

Similar Articles

Cited By